[
    [
        {
            "time": "2020-09-18",
            "original_text": "药明康德：HCII WX (HK) Holdings Limited 合计完成减持2378.88万股公司股份 减持股份",
            "features": {
                "keywords": [
                    "药明康德",
                    "减持",
                    "HCII WX",
                    "2378.88万股"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德：HCII WX (HK) Holdings Limited 合计完成减持2378.88万股公司股份 减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-09-18",
            "original_text": "药明康德：股东累计通过大宗交易减持1%股份，完成减持计划 减持股份数量",
            "features": {
                "keywords": [
                    "药明康德",
                    "股东",
                    "大宗交易",
                    "减持1%"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德：股东累计通过大宗交易减持1%股份，完成减持计划 减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-09-18",
            "original_text": "药明康德：HCIII WX (HK) Holdings Limited减持完毕 累计减持1%股份 减持股份",
            "features": {
                "keywords": [
                    "药明康德",
                    "HCIII WX",
                    "减持完毕",
                    "1%股份"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德：HCIII WX (HK) Holdings Limited减持完毕 累计减持1%股份 减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-09-18",
            "original_text": "野村：首予药明康德港股“买入”评级，目标价129港元",
            "features": {
                "keywords": [
                    "野村",
                    "药明康德",
                    "买入评级",
                    "129港元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "野村：首予药明康德港股“买入”评级，目标价129港元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]